海外の治験の状況「1」での検索結果
2657件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected Adults
- HIV Infections
- United States, Zimbabwe
- 2003-11-03
Not recruiting
- Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
- HIV Infections
- Australia, Belgium, Denmark, France, Greece, Ireland, Italy, Portugal, South Africa, Switzerland, United Kingdom, United States
- 2003-06-10
Not recruiting
- Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients
- HIV Infections
- Australia, Belgium, Canada, Denmark, France, Germany, Greece, Italy, Netherlands, Portugal, Switzerland, United Kingdom, United States
- 2003-03-19
Not recruiting
- Safety of and Immune Response to an HIV-1 Vaccine (ALVAC-HIV vCP1521) in Infants Born to HIV Infected Mothers
- HIV Infections
- Uganda
- 2004-12-03
Not recruiting
- TMC125-C216: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options.
- HIV
- Australia, Belgium, Canada, France, Germany, Italy, Netherlands, Poland, Portugal, Spain, United Kingdom, United States
- 2005-11-15
Not recruiting
- TMC125-C206: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options.
- HIV
- Argentina, Brazil, Chile, Costa Rica, France, Germany, Mexico, Panama, Puerto Rico, South Africa, Thailand, United Kingdom, United States
- 2005-11-10
Not recruiting
- Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis
- Ankylosing Spondylitis;Ankylosing Spondylitis;Ankylosing Spondylitis;Ankylosing Spondylitis
- Australia, Austria, China, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Netherlands, Poland, Portugal, Qatar, Saudi Arabia, Spain, Sweden, Switzerland, United Kingdom
- 2005-10-31
Not recruiting
- Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT)
- Metabolic Syndrome;Dyslipidemia
- Australia
- 2005-10-16
Not recruiting
- A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome
- Metabolic Syndrome;Dyslipidemia
- Australia
- 2005-10-16
Not recruiting
- Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes
- Diabetes Mellitus, Type 2
- Australia, Greece, India, Netherlands, Poland, Puerto Rico, United States
- 2005-09-12
Not recruiting
- Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis
- Arthritis, Rheumatoid;Arthritis, Rheumatoid;Arthritis, Rheumatoid;Arthritis, Rheumatoid
- Australia, Austria, Belgium, Brazil, Chile, Colombia, Czech Republic, Former Serbia and Montenegro, France, Germany, Hungary, Italy, Korea, Democratic People's Republic of, Korea, Republic of, Mexico, Netherlands, Poland, Russian Federation, Serbia, Spain, Sweden, Taiwan, United Kingdom
- 2007-11-28
Not Recruiting
- Antiviral effect, safety and pharmacokinetics of BI 201335 NA in hepatitis C virus genotype 1 infected treatment-naïve and treatment-experienced patients for 24 weeks as combination therapy with pegylated interferon-a 2a and ribavirin (doubleblinded, randomised, placebo-controlled, Phase II).
- chronic hepatitis C infection of genotype 1 MedDRA version: 14.0 Level: LLT Classification code 10047457 Term: Viral hepatitis C System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Virus Diseases [C02];chronic hepatitis C infection of genotype 1 MedDRA version: 14.0 Level: LLT Classification code 10047457 Term: Viral hepatitis C System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
- Argentina, Australia, Austria, Canada, Czech Republic, France, Germany, Korea, Republic of, Netherlands, Portugal, Romania, Spain, United Kingdom, United States
- 2008-07-24
Recruiting
- A Pilot Study Examining the Efficacy of a Support Algorithm for Commencing Patients with Type 2 Diabetes on a Basal / Prandial Insulin Regimen in the Primary Care Setting With Professional Continuous Glucose Monitoring as an Adjunct.
- Type 2 Diabetes
- Australia
- 2010-09-24
Not recruiting
- A Phase 1 randomized study to compare the safety and immune response of an oral rotavirus vaccine, RV3-BB, and placebo for the prevention of rotavirus disease in infants, children and male adults.
- Rotavirus gastroenteritis
- Australia
- 2010-06-25
Not Recruiting
- A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
- Prostate Cancer Metastatic;C61 - Malignant neoplasm of prostate
- Australia, Belgium, Canada, Denmark, Estonia, France, Germany, Iceland, Israel, Netherlands, Poland, Puerto Rico, Russian Federation, Spain, United Kingdom, United States
- 2012-12-05
Not Recruiting
- Compare the Efficacy and Safety of Gentian Violet to that of Nystatin used in the treatment of fungal infection of the mouth in patients infected HIV-1
- HIV Infections
- Botswana, India, Kenya, Malawi, South Africa, Uganda, Zimbabwe
- 2012-12-03
Not Recruiting
- LUX-Breast 1; An Open Label, Randomised Phase III Trial of BIBW 2992 and Vinorelbine Versus Trastuzumab and Vinorelbine in Patients With Metastatic HER2-overexpressing Breast Cancer Failing One Prior Trastuzumab Treatment
- Breast Neoplasms;C50 - Malignant neoplasm of breast
- Argentina, Australia, Austria, Belarus, Belgium, Brazil, Canada, Chile, China, Czech Republic, Egypt, France, Germany, India, Ireland, Israel, Italy, Japan, Korea, Republic of, Latvia, Lebanon, Lithuania, Mexico, Netherlands, Peru, Poland, Portugal, Russian Federation, Singapore, Slovakia, Slovenia, South Africa, Spain, Sri Lanka, Taiwan, Province of China, Turkey, United Kingdom, United States
- 2012-11-30
- AN INTERNATIONAL, RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY OF RINDOPEPIMUTC/GM-CSF WITH ADJUVANT TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED, SURGICALLY RESECTED, EGFRVIII-POSITIVE GLIOBLASTOMA
- Australia, Brazil, Canada, Colombia, Czech Republic, Greece, Hungary, India, Mexico, New Zealand, Taiwan, Thailand, United States
- 2012-11-15
Not recruiting
- A Phase 1/2 study to determine the effect of Doxorubicin loaded EnGeneIC Delivery Vehicles on progression free survival in Patients with Recurrent Glioblastoma Multiforme (GBM)
- Recurrent Glioblastoma Multiforme
- Australia
- 2013-03-18
Not Recruiting
- Chemotherapy-induced alopecia (CIA) in breast cancer patients: effectiveness of two temperature levels of scalp cooling on reducing rates of CIA.
- chemotherapy-induced alopecia;breast cancer; chemotherapy-induced alopecia breast cancer;Cancer - Breast
- Australia
- 2015-10-21
